The NXDC-MEN-301 Study on 5-ALA for Meningiomas Surgery: An Innovative Study Design for the Assessing the Benefit of Intra-Operative Fluorescence Imaging

Background: 5-aminolevulinic acid (5-ALA; Gleolan(TM), NX Development Corps., Lexington, USA) is approved for fluorescence-guided resections of suspected malignant gliomas. Experience has demonstrated that meningiomas also show fluorescence, which may be a useful surgical adjunct. We present an inno...

Descripción completa

Detalles Bibliográficos
Autores principales: Stummer, Walter, Holling, Markus, Bendok, Bernard R., Vogelbaum, Michael A., Cox, Ashley, Renfrow, Sara L., Widhalm, Georg, Ezrin, Alan, DeSena, Salvatore, Sackman, Murray L., Wyse, Joseph W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405714/
https://www.ncbi.nlm.nih.gov/pubmed/36009108
http://dx.doi.org/10.3390/brainsci12081044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405714/
https://www.ncbi.nlm.nih.gov/pubmed/36009108
http://dx.doi.org/10.3390/brainsci12081044

Ejemplares similares